Human Platelet Lysate Market was valued at USD 45 Million in 2017 and predicted to grow at 3.9% CAGR over the forecast period.

Human platelet lysate is a growth factor-rich cell culture supplement derived from healthy donor human platelets. Human platelet lysate is used in various applications, such as mesenchymal stem cell (MSC) culture, cell-based therapy, therapeutics production, stem cell and others.

To have an edge over the competition by knowing the market dynamics and current trends of “human platelet lysate”, request for Sample Report here

Rising adoption of human platelet lysate in place of fetal bovine serum, funding for life science research and investments, adoption of advanced blood collection and processing technology in emerging countries are the major drivers expected to positively influence the growth of global human platelet lysate market in the coming years. In addition, increasing research & development activities and surging demand for animal-free serum media are likely to spur the growth of global human platelet lysate market. Emergence of innovative technologies, such as stem cell and cell-based therapeutics are also predicted to increase demand for human platelet lysate. However, price constraints, lack of awareness and availability of alternative products may hamper the growth of human platelet lysate market across the globe during the forecast period.

Do you want to know more about the Research process and detailed Methodology, Request Research Methodology of this report

The cell culture industry paradigm tends to shift from bovine to animal-free serum, thus, regional governments are adopting European guidelines for culturing the media for any therapeutic products. This shift is likely to help human platelet lysate to become an attractive alternative to the serum supplement in area of cell culturing, which is expected to increase demand for human platelet lysate during the forecast period. The global human platelet lysate market has tremendous growth potential owing to increasing regulatory approvals for vaccine production via cell culture-based and well-developed research centers and institutes.

Various notable players operating in the market, include Merck KGaA, Compass Biomedical Inc., Macopharma SA, Cook Medical (Cook Regentec), Mill Creek Life Sciences Llc., Stemcell Technologies Inc., Zen-Bio, Inc., Sclavo Diagnostics International Srl, Life Science Production, and Trinova Biochem Gmbh, among others. Most of the companies are focusing on new batch technology for the production of human platelet lysates, thereby, aiding the global human platelet lysate market.

In case, any of your pain points areas are not covered in the current scope of this report, Request for Free Customization here

The global human platelet lysate market has been segmented on the basis of product type, application, end-user and key geographies. Based on product type, the market comprises of heparin-free platelet lysate and platelet lysate with heparin. Based on application, the market has been segmented into research use and clinical use. The end use areas include research institutes, biopharmaceutical companies and others.

The research report “global human platelet lysate market” provides in-depth analysis of global human platelet lysate market based on product type, application, end user and major geographies for the forecast period from 2018 to 2025. The report also highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for the global human platelet lysate market. In addition, the report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

For detailed scope of the “human platelet lysate market” report request a Sample Copy of the report

Key questions answered in this research report:
1. At what pace is the human platelet lysate market growing, globally? What will be growth trend in future?
2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the global human platelet lysate market?
4. What are the various application areas and how they are poised to grow?

Market Segmentation

Product Type
• Heparin-free Platelet Lysate
• Platelet Lysate with Heparin

Application
• Research Use
• Clinical Use

End User
• Research Institutes
• Biopharmaceutical Companies
• Others

Geography
• North America
As a part of customization
o By Product Type
o By Application
o By End User
o United States
o Canada
o Mexico

• Europe
As a part of customization
o By Product Type
o Application
o By End User
o United Kingdom
o Germany
o Spain
o Rest of Europe

• Asia-Pacific
As a part of customization
o By Product Type
o By Application
o By End User
o China
o Australia
o India
o Rest of Asia-Pacific

• Rest of the World
As a part of customization
o By Product Type
o By Application
o By End User
o Brazil
o South Africa
o GCC Countries
o Rest of the World (remaining countries of the LAMEA region)

Leading Market Players
• Merck KGaA
• Compass Biomedical Inc.
• Macopharma SA
• Cook Medical (Cook Regentec)
• Mill Creek Life Sciences LLc.
• Stemcell Technologies Inc.
• Zen-Bio, Inc.
• PL BioScience
• Life Science Production
• Trinova Biochem GmbH

*Other prominent players in the market which can be profiled as a part of customization:

BBI Solutions.
Sclavo Diagnostics International Srl
AventaCell BioMedical Corp.